8Y7L
Crystal Structure of Nur77 LBD in complex with N-(2'-(4-hydroxypiperidin-1-yl)-[4,4'-bipyridin]-2-yl)cinnamamide
This is a non-PDB format compatible entry.
Summary for 8Y7L
Entry DOI | 10.2210/pdb8y7l/pdb |
Descriptor | Nuclear receptor subfamily 4immunitygroup A member 1, (~{E})-~{N}-[4-[2-(4-oxidanylpiperidin-1-yl)pyridin-4-yl]pyridin-2-yl]-3-phenyl-prop-2-enamide (3 entities in total) |
Functional Keywords | complex, transcription |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 53410.08 |
Authors | |
Primary citation | Chen, J.,Zhao, T.,Hong, W.,Li, H.,Ao, M.,Zhong, Y.,Chen, X.,Qiu, Y.,Wang, X.,Wu, Z.,Lin, T.,Li, B.,Chen, X.,Fang, M. Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy Acta Pharm Sin B, 2024 Cited by DOI: 10.1016/j.apsb.2024.07.012PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.683 Å) |
Structure validation
Download full validation report